These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1030296)

  • 1. Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
    Harris GD; Johnason WG; Nicholson D
    Bull Int Union Tuberc; 1976; 51(1):275-8. PubMed ID: 1030296
    [No Abstract]   [Full Text] [Related]  

  • 2. [A case of Mycobacterium kansasii lung infection developed after treatment of Mycobacterium gordonae lung infection].
    Umeki S; Okamoto Y; Hara Y
    Kekkaku; 1988 Dec; 63(12):785-90. PubMed ID: 3226033
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin.
    Donta ST; Smith PW; Levitz RE; Quintiliani R
    Arch Intern Med; 1986 May; 146(5):902-4. PubMed ID: 3963983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Australian rifampicin trial.
    Proust A; Evans C
    Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulmonary infection due to Mycobacterium malmoense].
    Handrick W; Schwede I; Ebeling O; Wogawa B; Berthold F
    Pneumologie; 2005 Apr; 59(4):244-7. PubMed ID: 15944898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated cutaneous Mycobacterium marinum infection.
    King AJ; Fairley JA; Rasmussen JE
    Arch Dermatol; 1983 Mar; 119(3):268-70. PubMed ID: 6824363
    [No Abstract]   [Full Text] [Related]  

  • 7. Sporotrichoid Mycobacterium marinum infection in diabetes. Chemotherapy with rifampin and ethambutol.
    Bodaness RS
    N Y State J Med; 1978 Oct; 78(12):1935-6. PubMed ID: 279836
    [No Abstract]   [Full Text] [Related]  

  • 8. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.
    Griffith DE; Brown-Elliott BA; Wallace RJ
    Clin Infect Dis; 2003 Nov; 37(9):1178-82. PubMed ID: 14557961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA; Nagel DA
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M; Andrzejczyk Z; Marczewska J
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
    Bogaerts Y; Elinck W; van Renterghem D; Pauwels R; van der Straeten M
    Eur J Respir Dis; 1982 Jul; 63(4):298-304. PubMed ID: 7117427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia.
    Meyer JJ; Gelman SS
    J Infect; 2008 Feb; 56(2):151-4. PubMed ID: 18199481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
    Rev Mal Respir; 1989; 6(4):335-42. PubMed ID: 2552547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ten-year clinical experience with Mycobacterium kansasii.
    Rauscher CR; Kerby G; Ruth WE
    Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.
    Harris GD; Johanson WG; Nicholson DP
    Am Rev Respir Dis; 1975 Jul; 112(1):31-6. PubMed ID: 1147382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P; Schilling W
    Z Erkr Atmungsorgane; 1984; 162(1):26-9. PubMed ID: 6202070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
    Tsukamura M; Yamori S
    Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and long-term follow-up of patients with atypical mycobacterial infections.
    Davidson PT
    Bull Int Union Tuberc; 1976; 51(1):257-61. PubMed ID: 1030293
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study on experimental mycobacterioses provoked by atypical mycobacteria. 2. Combined antituberculous chemotherapy against conventional mice infected intravenously with Mycobacterium intracellulare (author's transl)].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1979 Sep; 54(9):453-60. PubMed ID: 502152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.